02. August 2016

Impact of the EU referendum on pharma still unclear The European pharmaceutical industry faces a prolonged period of uncertainty in the wake of the UK referendum vote on EU membership, with the future location of the European Medicines Agency (EMA) high on the list of questions raised by the leave vote. As the EMA is located in London, Brexit means that the agency will likely be relocated to an EU member state, with Italy and Spain the latest candidates to throw their hats into the ring. At the...